Treatment Options for Your Patients
Optimal treatment strategy for vasomotor symptom control
Women with low estrogen levels may experience numerous symptoms that vary in severity and duration before, during, and after menopause. As women transition through menopause, vasomotor changes may be some of the most prevalent symptoms experienced.
When devising a treatment strategy for your patients, it's important to keep in mind the use of estrogen, alone or in combination with a progestin, should be prescribed at the lowest effective dose and for the shortest duration consistent with treatment goals and risks for the individual woman. Educate your patients on the facts about hormone therapy. Empower them to continue the treatment dialogue with you. This will provide your patients with the clarity and confidence they need to embrace a treatment approach that's right for them.
Estrogen therapy has evolved considerably in recent years, and the differences in therapy type may impact your treatment strategy and management for patients. Current recommendations for hormone therapy from the U.S. Food and Drug Administration (FDA), North American Menopause Society (NAMS), and American College of Obstetricians and Gynecologists (ACOG) suggest using the lowest effective dose of estrogen for the shortest duration of time, consistent with treatment goals, benefits, and risks.10-12
Oral and transdermal estrogens are two types of hormone therapy approved and regulated by the FDA to reduce vasomotor symptoms due to menopause. Oral therapy is metabolized in the liver before entering the bloodstream. Transdermal treatment options are absorbed into the skin via patch, gel, cream, or spray.
Elestrin is a transdermal, low-dose estrogen therapy thats FDA-approved for the treatment of moderate-to-severe vasomotor symptoms due to menopause. Learn more about the benefits of Elestrin.
Other treatments for hot flushes
The term bioidentical can be confusing to many patients. Elestrin, and many FDA-approved treatments, contains an estradiol hormone that is an identical copy of the principal form of estrogen in a womans body (called a bioidentical).4 Some products that are commonly referred to as bioidenticals are actually compounded at pharmacies.
These treatments have not been approved by the FDA, they may contain nonbioidentical elements, and clinical data may not be available for them. To read what the FDA has to say about bioidenticals, click here.13
Herbal products (e.g., black cohosh) and other over-the-counter treatments have also not been approved by the FDA and may not have clinical data available for them. Elestrin has been approved by the FDA and has been shown in a clinical study to reduce hot flushes.
Elestrin Patient Education Brochure
You and your patients have options when it comes to estrogen therapy. Naturally, you take into consideration many things when devising an effective treatment strategy for patients.
This Patient Education Brochure is a useful resource for your patients as they consider the treatment options.
Help your patients save with Elestrin
You can help your patients save with Elestrin. Your patients may pay as little as $25 on their Elestrin prescriptions.